Liver extracellular matrix in health and disease

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pathology

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1397PMID 12845618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver fibrosis

  2004cited by this paper
• INHIBITION OF LIVER FIBROGENESIS THROUGH NORADRENERGIC ANTAGONISM.

  2004cited by this paper
• Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis

  2003cited by this paper
• Approaches for treatment of liver fibrosis in chronic hepatitis C.

  2003cited by this paper
• Transforming Growth Factor β1 Induces Apoptosis through Cleavage of BAD in a Smad3-Dependent Mechanism in FaO Hepatoma Cells

  2002cited by this paper
• Hypoxia‐induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

  2002cited by this paper
• Dystroglycan Expression in Hepatic Stellate Cells: Role in Liver Fibrosis

  2002cited by this paper
• Roles of TGF-beta in hepatic fibrosis.

  2002cited by this paper
• Noninvasive monitoring of patients with chronic hepatitis C

  2002cited by this paper
• Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

  2002cited by this paper
• Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

  2002cited by this paper
• Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells.

  2002cited by this paper
• Mesenchymal cells in the liver--one cell type or two?

  2002cited by this paper
• Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

  2002cited by this paper
• Effects and Regulation of Connective Tissue Growth Factor on Hepatic Stellate Cells

  2002cited by this paper
• Dose‐dependent inhibition of hepatic fibrosis in mice by a TGF‐β soluble receptor: Implications for antifibrotic therapy

  2002cited by this paper
• Transcriptional regulation of hepatic stellate cell activation

  2002cited by this paper
• Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.

  2002cited by this paper
• Senescence, Telomere Shortening and Telomere Maintenance

  2002cited by this paper
• Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride.

  2002cited by this paper
• Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: Effect of N-acetylcysteine and interferon-α

  2001cited by this paper
• Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

  2001cited by this paper
• DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.

  2001cited by this paper
• Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

  2001cited by this paper
• Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

  2001cited by this paper
• Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas.

  2001cited by this paper
• Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha.

  2001cited by this paper
• Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.

  2001cited by this paper
• Hepatic fibrosis. Pathogenesis and principles of therapy.

  2001cited by this paper
• Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.

  2001cited by this paper
• Studies of murine schistosomiasis reveal interleukin‐13 blockade as a treatment for established and progressive liver fibrosis

  2001cited by this paper
• Is liver fibrosis reversible

  2001cited by this paper
• Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy

  2001cited by this paper
• Signal Transduction by the Chemokine Receptor CXCR3

  2001cited by this paper
• Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells

  2000cited by this paper
• Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP‐470 in rats

  2000cited by this paper
• New Genetic Tricks to Rejuvenate Ailing Livers

  2000cited by this paper
• Host genetic factors influence disease progression in chronic hepatitis C

  2000cited by this paper
• Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex.

  2000cited by this paper
• Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

  2000cited by this paper
• Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

  2000cited by this paper
• Pathogenesis of liver fibrosis: role of oxidative stress.

  2000cited by this paper
• Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

  2000cited by this paper
• Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy

  1999cited by this paper
• Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

  1999cited by this paper
• Hepatocyte growth factor gene therapy of liver cirrhosis in rats

  1999cited by this paper
• Cytokines and Fibrogenesis

  1999cited by this paper
• Soluble Arg-Gly-Asp Peptides Reduce Collagen Accumulation in Cultured Rat Hepatic Stellate Cells

  1999cited by this paper
• Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.

  1999cited by this paper
• Plasma Levels of Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitors of Metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as Noninvasive Markers of Liver Disease in Chronic Hepatitis C Comparison Using ROC Analysis

  1999cited by this paper
• Biology of Hepatic Stellate Cells and Their Possible Relevance in the Pathogenesis of Portal Hypertension in Cirrhosis

  1999influential reference
• Expression of connective tissue growth factor in experimental rat and human liver fibrosis

  1999cited by this paper
• Enhanced Th1 and Dampened Th2 Responses Synergize To Inhibit Acute Granulomatous and Fibrotic Responses in Murine Schistosomiasis Mansoni

  1999cited by this paper
• Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.

  1999cited by this paper
• Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo

  1998cited by this paper
• Hepatocytes as a source of collagen type XVIII endostatin.

  1998cited by this paper
• Computer morphometry for quantitative measurement of liver fibrosis: Comparison with Knodell's score, colorimetry and conventional description reports *

  1998cited by this paper
• Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

  1998cited by this paper
• Effect of insoluble extracellular matrix molecules on fas expression in epithelial cells

  1998cited by this paper
• Expression of Interleukin-10 by in Vitro and in Vivo Activated Hepatic Stellate Cells*

  1998cited by this paper
• Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

  1998cited by this paper
• Fibrogenic effect of oxidative stress on rat hepatic stellate cells

  1998cited by this paper
• Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4‐hydroxylase inhibitor

  1998cited by this paper
• Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

  1998cited by this paper
• Hepatic stellate cells

  1998cited by this paper
• Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis.

  1998cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.

  1997cited by this paper
• Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes.

  1997cited by this paper
• An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors.

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.

  1997cited by this paper
• CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair.

  1997cited by this paper
• Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

  1996cited by this paper
• Type I, II, III, IV, V, and VI Collagens Serve as Extracellular Ligands for the Isoforms of Platelet-derived Growth Factor (AA, BB, and AB)*

  1996cited by this paper
• Hepatic stellate cells.

  1996cited by this paper
• Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro.

  1996cited by this paper
• Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.

  1996cited by this paper
• Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair.

  1996cited by this paper
• A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene.

  1996cited by this paper
• Tissue inhibitor of metalloproteinase‐1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

  1996cited by this paper
• Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.

  1996cited by this paper
• Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling.

  1995cited by this paper
• Collagenases and liver fibrosis.

  1995cited by this paper
• Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells.

  1995cited by this paper
• Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein

  1995cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Malondialdehyde stimulates collagen production by hepatic lipocytes only upon activation in primary culture.

  1994cited by this paper
• Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis

  1994cited by this paper
• Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

  1994cited by this paper
• Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43.

  1993cited by this paper
• Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

  1993cited by this paper
• The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus.

  1993cited by this paper
• Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

  1993cited by this paper
• Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells.

  1993cited by this paper
• Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

  1993cited by this paper
• Capillarization and venularization of hepatic sinusoids in porcine serum‐induced rat liver fibrosis: A mechanism to maintain liver blood flow

  1993cited by this paper
• The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies

  1993cited by this paper

• Multi-omics reveals co-regulation of hepatic bile acid metabolism in laying hens by host genetics and the cecal Anaerostipes

  2026cites this paper
• Liver Extracellular Matrix in Colorectal Liver Metastasis

  2025cites this paper
• From cooperation to collapse: systemic failure in liver disease through a sociological lens

  2025cites this paper
• Integrative Computational Analysis of VCX2 in Hepatocellular Carcinoma: From Potential Biomarker Discovery to Therapeutic Targeting with Peruvian Natural Products

  2025cites this paper
• Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease

  2025cites this paper
• Associations among serum levels of MMP-1, MMP-2, and METAVIR fibrosis score in patients with nonalcoholic fatty liver disease

  2025cites this paper
• Extracellular Matrix Cues as Drivers of Liver Zonation: A Framework for In Vitro Biomaterial Design.

  2025cites this paper
• Laminin γ2 accelerates non-alcoholic fatty liver disease progression by enhancing lipid accumulation and fibrogenesis in hepatocytes.

  2025cites this paper
• Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology

  2025cites this paper
• Succinate Modulation as a Biochemical Correlate of Metabolic and Neurobehavioral Changes Associated With Intermittent Fasting in Obesity

  2025cites this paper
• A Pathophysiology‐Informed, Negentropy‐Oriented Strategy for Nanomedicine in MASLD

  2025cites this paper
• Disaccharide Analysis of Glycosaminoglycans From Twenty‐Four Organs of Young and Aged Mice

  2025cites this paper
• Research on the Mechanism of the lncRNA DLX6-AS1/miR-26a/PTEN Axis in Regulating the Activation of Hepatic Stellate Cells in Post-hepatitis Liver Fibrosis: An Analysis Based on Systematic Validation and Clinical Translation Methods

  2025cites this paper
• Application of tergitol in liver decellularization and bioink preparation based on the obtained extracellular matrix

  2025cites this paper
• Succinate Modulation as a Novel Mechanism Underlying the Effects of Intermittent Fasting on Brain Function and Metabolism in Diet-Induced Obesity

  2025cites this paper
• The Association and Mechanisms between Periodontitis and Chronic Hepatitis B

  2025cites this paper
• Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications

  2025cites this paper
• Matrix Tropism Influences Endometriotic Cell Attachment Patterns

  2025cites this paper
• Portulaca oleracea L. extract relieve mice liver fibrosis by inhibiting TLR-4/NF-κB, Bcl-2/Bax and TGF-β1/Smad2 signalling transduction

  2024cites this paper
• Collagen-rich liver-derived extracellular matrix hydrogels augment survival and function of primary rat liver sinusoidal endothelial cells and hepatocytes.

  2024cites this paper
• Hydrogel-Based Strategies for Liver Tissue Engineering

  2024cites this paper
• Hepatic organoids move from adolescence to maturity

  2024cites this paper
• Unleashing the Power of Undifferentiated Induced Pluripotent Stem Cell Bioprinting: Current Progress and Future Prospects

  2024cites this paper
• Hemodialysis bilayer bionic blood vessels developed by the mechanical stimulation of hepatitis B viral X (HBX) gene-transfected hepatic stellate cells

  2024cites this paper
• Nebivolol Exerts Hepatoprotective Activity During CLP-Induced Sepsis by Modulating Oxidative Stress, Liver Regeneration, and AKT/MAPK Pathways in Rats

  2024cites this paper
• Building in vitro models for mechanistic understanding of liver regeneration in chronic liver diseases.

  2024cites this paper
• Functionalized Gelatin/Polysaccharide Hydrogels for Encapsulation of Hepatocytes

  2024cites this paper
• miR-9-5p and miR-221-3p Promote Human Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Liver Injury by Enhancing Human Mesenchymal Stem Cell Engraftment and Inhibiting Hepatic Stellate Cell Activation

  2024cites this paper
• Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture

  2024cites this paper
• Current Landscape and Opportunities in the development of Bioengineered In-Vitro Vascularized Liver Tissue Models

  2024cites this paper
• Microenvironnement hépatique

  2023cites this paper
• Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration

  2023cites this paper
• Biofabrication methods for reconstructing extracellular matrix mimetics

  2023cites this paper
• The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability

  2023cites this paper
• Advances in Recellularization of Decellularized Liver Grafts with Different Liver (Stem) Cells: Towards Clinical Applications

  2023cites this paper
• Chronic Pancreatitis and Risk of Atherosclerotic Cardiovascular Disease

  2023cites this paper
• On the Diagnosis of Nonalcoholic Steatohepatitis Using Dielectric Properties: Feasibility in Mouse Model

  2023cites this paper
• Whole Liver Derived Acellular Extracellular Matrix for Bioengineering of Liver Constructs: An Updated Review

  2023cites this paper
• Decellularized Liver Nanofibers Enhance and Stabilize the Long‐Term Functions of Primary Human Hepatocytes In Vitro

  2023cites this paper
• Effect of Percutaneous Biliary Drainage on Enzyme Activity of Serum Matrix Metalloproteinase-9 in Patients with Malignant Hilar Obstructive Hyperbilirubinemia

  2023cites this paper
• Macrophage-derived cathepsin S remodels the extracellular matrix to promote liver fibrogenesis.

  2023cites this paper
• Biocompatibility evaluation of antioxidant cocktail loaded gelatin methacrylamide as bioink for extrusion-based 3D bioprinting

  2023cites this paper
• Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-analysis from an Omics Perspective

  2023cites this paper
• Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted

  2023cites this paper
• Mechanical Regulation of Mitochondrial Dynamics and Function in a 3D-Engineered Liver Tumor Microenvironment

  2023cites this paper
• Exploring the constituent mechanisms of hepatitis: a dynamical systems approach

  2022cites this paper
• Evolution of Electrospinning in Liver Tissue Engineering

  2022cites this paper
• Constructing biomimetic liver models through biomaterials and vasculature engineering

  2022cites this paper
• A Preliminary Investigation of Embedding In Vitro HepaRG Spheroids into Recombinant Human Collagen Type I for the Promotion of Liver Differentiation

  2022cites this paper
• Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids

  2022cites this paper
• Liver scaffolds obtained by decellularization: A transplant perspective in liver bioengineering

  2022cites this paper
• Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway.

  2022cites this paper
• 3D Silk Fibroin-Gelatin/Hyaluronic Acid/Heparan Sulfate Scaffold Enhances Expression of Stemness and EMT Markers in Cholangiocarcinoma

  2022cites this paper
• Biomaterials and bioengineering to guide tissue morphogenesis in epithelial organoids

  2022cites this paper
• Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice

  2022influential citation
• Hépatopathies de surcharge et cirrhose

  2022cites this paper
• Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis

  2022cites this paper
• Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis

  2022cites this paper
• The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis

  2022cites this paper
• Efficacy of the aqueous extract of Siwa dates in protection against the whole body γ irradiation induced damages in mice

  2021cites this paper
• Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems

  2021cites this paper
• Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge

  2021cites this paper
• Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells.

  2021cites this paper
• Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis

  2021cites this paper
• Engineering and Monitoring 3D Cell Constructs with Time-Evolving Viscoelasticity for the Study of Liver Fibrosis In Vitro

  2021cites this paper
• Necessity Exceptions to Takings

  2021cites this paper
• Characterizing and Engineering Biomimetic Materials for Viscoelastic Mechanotransduction Studies

  2021cites this paper
• Extracellular Matrix Remodeling in Chronic Liver Disease

  2021cites this paper
• An optomechanogram for assessment of the structural and mechanical properties of tissues

  2021cites this paper
• Extracellular matrix requirements for gastrointestinal organoid cultures.

  2021cites this paper
• Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.

  2021cites this paper
• Decellularized liver extracellular matrix for iPSC-based liver engineering

  2021cites this paper
• PDE4 inhibition: a novel therapeutic strategy in liver fibrosis.

  2021cites this paper
• Vascularization of hepatic structures in a microfluidic platform

  2021cites this paper
• Design and Evaluation of a Polypeptide That Mimics the Integrin Binding Site for EDA Fibronectin to Block Profibrotic Cell Activity

  2021cites this paper
• Polymeric Bioinks for 3D Hepatic Printing

  2021cites this paper
• Elucidating Extracellular Matrix and Stiffness Control of Primary Human Hepatocyte Phenotype via Cell Microarrays

  2021cites this paper
• The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR.

  2021cites this paper
• Investigating oxygen transport efficiencies in precision-cut liver slice-based organ-on-a-chip devices

  2021cites this paper
• Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment

  2020cites this paper
• It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis

  2020cites this paper
• Advances in the clinical use of collagen as biomarker of liver fibrosis

  2020cites this paper
• Advances in biomaterials for hepatic tissue engineering

  2020cites this paper
• Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases

  2020cites this paper
• Collagen-I and fibronectin modified three-dimensional electrospun PLGA scaffolds for long-term in vitro maintenance of functional hepatocytes.

  2020cites this paper
• Noninvasive Biomarkers for Liver Fibrosis

  2020cites this paper
• Hyaluronidase-2 Regulates RhoA Signaling, Myofibroblast Contractility, and Other Key Profibrotic Myofibroblast Functions

  2020cites this paper
• Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C

  2020cites this paper
• Collagen biology and non‐invasive biomarkers of liver fibrosis

  2020cites this paper
• INTEGRATED STUDY OF LIVER FIBROSIS: MODELING AND CLINICAL DETECTION

  2020cites this paper
• Limitations of non-invasive tests for assessment of liver fibrosis

  2020cites this paper
• A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis

  2020cites this paper
• Integrin Linked Kinase is Critical for Hepatic Cellular Organization, Metabolism, and Glucoregulation

  2019cites this paper
• Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis

  2019cites this paper
• Hydrogels for Liver Tissue Engineering

  2019cites this paper
• Blended electrospinning with human liver extracellular matrix for engineering new hepatic microenvironments

  2019cites this paper
• The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease.

  2019cites this paper
• Scaffolds for liver regeneration

  2019cites this paper
• Tissue engineering scaffold subtypes and methods for the production thereof

  2019cites this paper
• The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells.

  2019cites this paper